Research Topics: Tobacco Products
The following papers on tobacco products have been published by Tobacco Control Research Branch staff.
Bogen K, Biener L, Garrett CA, Allen J, Cummings KM, Hartman A, Marcus S, McNeill A, O'Connor RJ, Parascandola M, Pederson L. Surveillance indicators for potential reduced exposure products (PREPs): developing survey items to measure awareness. Harm Reduct J. 2009 Oct 19;6:27.
Burns DM, Dybing E, Gray N, Hecht S, Anderson C, Sanner T, O’Connor R, Djordjevic M, Dresler C, Hainaut P, Jarvis M, Opperhuizen A, Straif K (2008) Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tobacco Control 17, 132-141.
Clark, P.I., Gardiner, P.S., Djordjevic, M.V., Leischow, S.J., and Robinson, R.G. Menthol cigarettes: setting research the agenda. Nicotine and Tob. Res. Vol. 6, Supplement 1, S5- 9, February 2004.
Hatsukami DK, Hanson K, Briggs A, Parascandola M, Genkinger JM, O'Connor R, Shields PG. Clinical trials methods for evaluation of potential reduced exposure products. Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3143-95.
Henningfield, J. and Djordjevic, M.V. Menthol Cigarettes: Research needs and challenges. Nicotine and Tob. Res. Vol. 6, Supplement 1, S11-16, February 2004.
Melikian, A.A., Djordjevic, M.V., Chen, S., Richie, J.P., Jr., and Stellman, S.D. (2007) Effect of Delivered Dosage of Cigarette Smoke Toxins on the Levels of Urinary Biomarkers of Exposure. Cancer Epidemiology, Biomarkers, and Prevention, 16(7):1408-15.
Melikian, A.A., Djordjevic, M.V., Hosey, J., Zhang, J., Chen, S., Zang, E., Muscat, J., Stellman, S.D. Gender differences relative to smoking behavior and emission of toxins from mainstream cigarette smoke. Nicotine and Tobacco Research 9(3):377-387, 2007.
Muscat, J.E., Djordjevic, M.V., Colosimo, S., Stellman, S.D., and Richie, J.P. Jr. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer 103(7):1420-1426, 2005.
O'Connor RJ, Cummings KM, Rees VW, Connolly GN, Norton KJ, Sweanor D, Parascandola M, Hatsukami DK, Shields PG. Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example. Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3334-48.
Parascandola, M. Lessons from the History of Tobacco Harm Reduction: The National Cancer Institute’s Smoking and Health Program and the "less hazardous cigarette". Nicotine Tob Res. 2005; 7(5): 779-789.
Parascandola, M. Science, industry, and tobacco harm reduction: A case study of tobacco industry scientists’ involvement in the National Cancer Institute’s Smoking and Health Program, 1964-1980. Public Health Rep. 2005; 120(3): 338-349.
Parascandola M, Augustson E, O'Connell ME, Marcus S. Consumer awareness and attitudes related to new potential reduced-exposure tobacco product brands. Nicotine Tob Res. 2009 Jul;11(7):886-95. Epub 2009 Jun 18.
Parascandola M, Augustson E, Rose A. Characteristics of current and recent former smokers associated with the use of new potential reduced-exposure tobacco products. Nicotine Tob Res. 2009 Dec;11(12):1431-8. Epub 2009 Nov 13.
Parascandola, M., Hurd, A.L., Augustson, E. Consumer Awareness and Attitudes Related to New Potential Reduced-Exposure Tobacco Products. Am J Health Behav. 2008; 32(4): 431-437.
Rees VW, Kreslake JM, Cummings KM, O'Connor RJ, Hatsukami DK, Parascandola M, Shields PG, Connolly GN. Assessing consumer responses to potential reduced-exposure tobacco products: a review of tobacco industry and independent research methods. Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3225-40.
Rees VW, Kreslake JM, O'Connor RJ, Cummings KM, Parascandola M, Hatsukami D, Shields PG, Connolly GN. Methods used in internal industry clinical trials to assess tobacco risk reduction. Cancer Epidemiol Biomarkers Prev. 2009Dec;18(12):3196-208.